Evolution Wealth Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$77.28 - $99.42 $14,683 - $18,889	-190 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$65.97 - $92.48 $15,305 - $21,455	-232 Reduced 54.98%	190 $18,000
Q2 2021 Jul 22, 2021	BUY	$69.38 - $86.75 $2,775 - $3,470	40 Added 10.47%	422 $33,000
Q1 2021 Apr 20, 2021	BUY	$72.25 - $168.95 $12,138 - $28,383	168 Added 78.5%	382 $28,000
Q4 2020 Feb 02, 2021	SELL	$125.56 - $178.74 $2,762 - $3,932	-22 Reduced 9.32%	214 $36,000
Q3 2020 Oct 15, 2020	BUY	$127.12 - $172.34 $2,669 - $3,619	21 Added 9.77%	236 $33,000
Q2 2020 Jul 27, 2020	SELL	$93.0 - $171.7 $2,976 - $5,494	-32 Reduced 12.96%	215 $34,000
Q1 2020 Apr 22, 2020	BUY	$82.38 - $131.64 $3,954 - $6,318	48 Added 24.12%	247 $24,000
Q4 2019 Feb 03, 2020	BUY	$76.53 - $135.58 $14,004 - $24,811	183 Added 1143.75%	199 $26,000
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $10,775 - $23,222	-148 Reduced 90.24%	16 $1,000
Q2 2019 Jul 12, 2019	BUY	$112.21 - $151.95 $18,402 - $24,919	164 New	164 $25,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.